Skip to main content

Corporate insider profile

Stephen J. Hill Insider Trades

Stephen J. Hill has reported no open-market purchases on SEC Form 4 and is a net seller of $19,731 across 1 company. The most recent open-market transaction was reported on Nov 10, 2026. Source: SEC Form 4 filings.

Latest reported as Chief Operating Officer of Lyell Immunopharma, Inc. (LYEL).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$19,731.04
Latest transaction
Nov 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 10, 2026Lyell Immunopharma, Inc. (LYEL)Chief Operating OfficerSale88$15.93$1,402
Aug 21, 2026Lyell Immunopharma, Inc. (LYEL)Chief Operating OfficerSale989$15.54$15,369
Aug 10, 2026Lyell Immunopharma, Inc. (LYEL)Chief Operating OfficerSale89$14.34$1,276
May 11, 2026Lyell Immunopharma, Inc. (LYEL)Chief Operating OfficerSale89$18.92$1,684

Common questions

Stephen J. Hill insider trading FAQ

Is Stephen J. Hill buying or selling stock?
Across all SEC Form 4 open-market filings on record, Stephen J. Hill is a net seller of $19,731, with no open-market purchases reported. The latest transaction was reported on Nov 10, 2026.
Which companies does Stephen J. Hill report insider trades for?
Stephen J. Hill has reported open-market trades in Lyell Immunopharma, Inc. (LYEL). The latest SEC-reported relationship is Chief Operating Officer of Lyell Immunopharma, Inc. (LYEL).
Where does Stephen J. Hill's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1866154, and refreshes this page daily.